These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34951635)

  • 41. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
    Tang C; Li X; Tang S; Wang Y; Tan X
    Endocr J; 2020 Mar; 67(3):249-255. PubMed ID: 31748429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
    Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
    O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
    J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
    Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome.
    Bicer M; Alarslan P; Guler A; Demir I; Aslanipour B; Calan M
    J Endocrinol Invest; 2020 Mar; 43(3):305-313. PubMed ID: 31486991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
    J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism.
    Auer MK; Hawley JM; Lottspeich C; Bidlingmaier M; Sappl A; Nowotny HF; Tschaidse L; Treitl M; Reincke M; Keevil BG; Reisch N
    Eur J Endocrinol; 2022 Dec; 187(6):K47-K53. PubMed ID: 36239921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
    Al Nofal A; Viers LD; Javed A
    Gynecol Endocrinol; 2017 Nov; 33(11):882-887. PubMed ID: 28649885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.
    Glintborg D; Jensen RC; Bentsen K; Schmedes AV; Brandslund I; Kyhl HB; Bilenberg N; Andersen MS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3819-3827. PubMed ID: 30060213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
    Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
    Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome.
    Yoshida T; Matsuzaki T; Miyado M; Saito K; Iwasa T; Matsubara Y; Ogata T; Irahara M; Fukami M
    Endocr J; 2018 Oct; 65(10):979-990. PubMed ID: 30012903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High androgen concentrations in follicular fluid of polycystic ovary syndrome women.
    Bongrani A; Plotton I; Mellouk N; Ramé C; Guerif F; Froment P; Dupont J
    Reprod Biol Endocrinol; 2022 Jun; 20(1):88. PubMed ID: 35701786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.